ProMetic Life Sciences Inc.
TSX : PLI

ProMetic Life Sciences Inc.

November 02, 2007 14:00 ET

ProMetic to Present at Acumen BioFin's Ninth Annual Healthcare Conference

MONTREAL, QUEBEC, CANADA--(Marketwire - Nov. 2, 2007) - ProMetic Life Sciences Inc. (TSX:PLI)("ProMetic") today announced that Mr. Pierre Laurin, President and Chief Executive Officer, will present at the upcoming Acumen BioFin's Ninth Annual Healthcare Conference. Acumen BioFin is a division of Rodman & Renshaw, LLC. ProMetic's presentation is scheduled for 16:25 (Eastern Time) on Tuesday, November 6, 2007. The conference will be held from November 5 - 7, 2007 at the New York Palace Hotel in New York. Details regarding the conference can be obtained at www.rodmanandrenshaw.com.

Individuals may listen to a live web cast of the presentation by logging on to ProMetic's web site, www.prometic.com a few minutes prior to start time to download any necessary software.

About ProMetic Life Sciences Inc.

ProMetic Life Sciences Inc. (www.prometic.com) is a biopharmaceutical company specialized in the research, development, manufacture and marketing of a variety of commercial applications derived from its proprietary Mimetic Ligand™ technology. This technology is used in large-scale purification of biologics and the elimination of pathogens. ProMetic is also active in therapeutic drug development with the mission to bring to market effective, innovative, lower cost, less toxic products for the treatment of hematology and cancer. Its drug discovery platform is focused on replacing complex, expensive proteins with synthetic "drug-like" protein mimetics. Headquartered in Montreal (Canada), ProMetic has R&D facilities in the UK, the USA and Canada, manufacturing facilities in the UK and business development activities in the USA, Europe, Asia and in the Middle-East.

Contact Information